In young children with incessant ventricular tachycardia and severe ventricular dysfunction, the management of tachycardia with conventional antiarrhythmic drugs remains a major therapeutic challenge because most of these drugs can further depress myocardial function. We report a four year old boy with verapamil responsive incessant ventricular tachycardia and severe ventricular dysfunction in whom oral verapamil treatment eliminated both the arrhythmia and the picture of dilated cardiomyopathy. On oral verapamil, the patient remains asymptomatic without recurrence of the ventricular tachycardia over a follow up period of 10 months.
Idiopathic verapamil responsive left ventricular tachycardia with a QRS pattern of right bundle branch block and left axis deviation has been well described as a distinct arrhythmia entity in patients without apparent heart disease.' 2 This variety of ventricular tachycardia is usually well tolerated and is not often associated with tachycardia induced cardiomyopathy. To the best of our knowledge, it has rarely been reported in patients younger than 10 years. There are no published data concerning the acute and chronic efficacy of oral verapamil in very young children with this unique type of arrhythmia associated with tachycardia induced cardiomyopathy.
We describe here a four year old boy with verapamil responsive incessant ventricular tachycardia and severe ventricular dysfunction in whom oral verapamil treatment eliminated both the arrhythmia and the picture of dilated cardiomyopathy. The experience with our patient shows that despite the associated severe ventricular dysfunction, oral verapamil can be effective and safe for acute termination and chronic prophylaxis of the arrhytimia in young children with verapamil responsive ventricular tachycardia. However, further studies are needed to assess the long term efficacy and safety of oral verapamil in this setting.
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